A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial
Steven D Gore, Pierre Fenaux, Valeria Santini, John M Bennett, Lewis R Silverman, John F Seymour, Eva Hellstrom-Lindberg, Arlene S Swern, Charles L Beach, Alan F List
Haematologica | FERRATA STORTI FOUNDATION | Published : 2013
Awarded by NATIONAL CANCER INSTITUTE
This work was supported by Celgene Corporation, Summit, NJ, USA.